- About the PharmD
- Admissions
- Admissions Overview
- Policies and Disclosures
- Financial Aid and Cost
- Application Process
- Application Process Overview
- Step 1: Minimum Eligibility Requirements
- Step 2: The Application
- Step 3: Interview Process
- Step 4: After Applying
- Frequently Asked Questions and Tips
- Applying Without U.S. Citizenship or Permanent Resident Status
- PharmD-PhD Dual Degree
- Post-Baccalaureate Program
- Student Life
- Curriculum
- Connect
- Info For...
News
Warif Kastoun, PharmD
Mon Jun 10, 2024
Nearly a third of the University of California’s Class of 2024 started their higher education journey at California community colleges, including Warif Kastoun, PharmD, whose plans to run her own local pharmacy in Damascus, Syria, were interrupted by civil war.
Wed Dec 16, 2015
How do you discover new drugs against diseases such as cancer?
A commonly used modern method is to screen thousands of chemical compounds against genetically identical laboratory-grown cancer cells (cell lines), then track how those compounds alter the cells’ behavior or appearance (phenotype). For example, does exposure to a compound...
Tue Dec 15, 2015
Despite Congressional mandates aimed at diversifying clinical research, little has changed in the last 30 years in both the numbers of studies that include minorities and the diversity of scientists being funded, according to a new analysis by researchers at UC San Francisco.
That lack of diversity could have a serious impact on our...
Tue Dec 8, 2015
Reprinted courtesy of UCSF Magazine.
In the pediatric bone marrow transplant clinic, pharmacist Janel Boyle’s past and present collide.
She drifts past young patients—many of them infants and toddlers—and notes their beaming smiles and balding heads. Her gaze shifts to the parents, their expressions tense but hopeful....
Wed Nov 18, 2015
Our faculty member Adam Abate, PhD, was selected by the World Economic Forum (WEF) as one of 45 exceptional Young Scientists—all under the age of 40—each of whom has contributed to advancing the frontiers of science, engineering, or technology in areas of high societal impact.
Abate attended the World Economic Forum’s Ninth Annual...
Tue Nov 17, 2015
Cataracts are the leading cause of blindness worldwide, the leading cause of vision loss in the United States, and cases are increasing with an aging population. Currently the condition can be treated with surgery—an expensive intervention that leaves most patients blinded in developing countries untreated.
A cataract occurs when the...
Mon Nov 9, 2015
More than a quarter of all drugs work by targeting one of a large family of proteins called G-protein-coupled receptors (GPCRs). Hundreds of different GPCRs are embedded in cell membranes, converting stimuli from the outside world—neurotransmitters, hormones, even light—into intracellular signals that can change cell behavior.
There are...
Thu Nov 5, 2015
In people with type 2 diabetes, the body is less able to use the hormone insulin to regulate blood sugar. The disease affects 350 million patients globally—including 29 million in the United States, where it is the leading cause of blindness, kidney failure, and non-accident-related amputations.
Metformin is the most widely used initial...
Tue Nov 3, 2015
Strategic planning; Recently received research funding: cancer, Alzheimer's, HIV, type 2 diabetes (Kroetz, Keiser, Gross, Roy); Recent faculty publications: fibrosis, biofilms, gout (DeGrado, Yang, Giacomini); Collaborations and partnerships; Patient care: SB 493, scope of practice for California pharmacists; Education: Precision Medicine Student...
Tue Nov 3, 2015
The research journey toward building a fully functioning, surgically implantable artificial kidney as an alternative to kidney transplant and dialysis just took another step forward with the announcement of a $6 million grant to The Kidney Project, headquartered at the UCSF School of Pharmacy. The funding comes from the National Institute of...